SS
JAZZ icon

Steve Schonfeld’s Jazz Pharmaceuticals JAZZ Stock Holding History

Steve Schonfeld’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Buy
77,272
+15,130
+24% +$3.31M 0.07% 263
2026
Q1 		$11.7M Sell
62,142
-77,075
-55% -$13.5M 0.08% 263
2025
Q4 		$23.7M Sell
139,217
-297,226
-68% -$45.6M 0.1% 164
2025
Q3 		$57.5M Buy
436,443
+373,383
+592% +$44.8M 0.33% 34
2025
Q2 		$6.69M Buy
63,060
+35,890
+132% +$3.9M 0.05% 464
2025
Q1 		$3.37M Sell
27,170
-2,147
-7% -$280K 0.02% 686
2024
Q4 		$3.61M Sell
29,317
-65,533
-69% -$7.72M 0.02% 613
2024
Q3 		$10.6M Buy
+94,850
New +$10.4M 0.07% 286
2024
Q1 		– Sell
-4,311
Closed -$530K – 2230
2023
Q4 		$530K Buy
+4,311
New +$538K ﹤0.01% 1270
2022
Q3 		– Sell
-21,099
Closed -$3.29M – 3072
2022
Q2 		$3.29M Buy
+21,099
New +$3.25M 0.03% 590
2021
Q2 		– Sell
-20,531
Closed -$3.37M – 2116
2021
Q1 		$3.37M Buy
+20,531
New +$3.38M 0.04% 538
2019
Q3 		– Sell
-1,489
Closed -$212K – 1125
2019
Q2 		$212K Buy
+1,489
New +$200K 0.01% 876
2017
Q2 		– Sell
-7,402
Closed -$1.07M – 691
2017
Q1 		$1.07M Buy
+7,402
New +$964K 0.11% 246

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Steve Schonfeld's JAZZ Position: Q2 2026 in Review

Steve Schonfeld increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q2 2026, buying an estimated $3.31M and bringing the position to 77,272 shares worth $18.6M. The position accounts for 0.07% of the portfolio, ranked #263.

Steve Schonfeld first reported a position in JAZZ in Q1 2017 and has held it in 13 quarters since. The position peaked at $57.5M in Q3 2025. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Steve Schonfeld held 77,272 shares of Jazz Pharmaceuticals worth $18.6M as of Q2 2026.
  • Steve Schonfeld bought 15,130 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.31M.
  • Jazz Pharmaceuticals made up 0.07% of Steve Schonfeld's portfolio in Q2 2026, its #263 holding.
  • Steve Schonfeld first reported a position in Jazz Pharmaceuticals in Q1 2017 and has held it in 13 quarters since.
  • Steve Schonfeld's Jazz Pharmaceuticals position peaked at $57.5M in Q3 2025.
  • 640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.